Braf Citations (15)

Originally described in: A computationally engineered RAS rheostat reveals RAS-ERK signaling dynamics.
Rose JC, Huang PS, Camp ND, Ye J, Leidal AM, Goreshnik I, Trevillian BM, Dickinson MS, Cunningham-Bryant D, Debnath J, Baker D, Wolf-Yadlin A, Maly DJ Nat Chem Biol. 2016 Nov 21. doi: 10.1038/nchembio.2244. PubMed Journal

---

Articles Citing Braf

Articles
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Chakraborty R, Hampton OA, Shen X, Simko SJ, Shih A, Abhyankar H, Lim KP, Covington KR, Trevino L, Dewal N, Muzny DM, Doddapaneni H, Hu J, Wang L, Lupo PJ, Hicks MJ, Bonilla DL, Dwyer KC, Berres ML, Poulikakos PI, Merad M, McClain KL, Wheeler DA, Allen CE, Parsons DW. Blood. 2014 Nov 6;124(19):3007-15. doi: 10.1182/blood-2014-05-577825. Epub 2014 Sep 8. PubMed
Methionine adenosyltransferase 2B-GIT1 complex serves as a scaffold to regulate Ras/Raf/MEK1/2 activity in human liver and colon cancer cells. Peng H, Li TW, Yang H, Moyer MP, Mato JM, Lu SC. Am J Pathol. 2015 Apr;185(4):1135-44. doi: 10.1016/j.ajpath.2014.12.016. PubMed
Recognition of enzymes lacking bound cofactor by protein quality control. Martinez-Limon A, Alriquet M, Lang WH, Calloni G, Wittig I, Vabulas RM. Proc Natl Acad Sci U S A. 2016 Oct 25;113(43):12156-12161. Epub 2016 Oct 12. PubMed
Mechanism of BRAF Activation through Biochemical Characterization of the Recombinant Full-Length Protein. Cope N, Candelora C, Wong K, Kumar S, Nan H, Grasso M, Novak B, Li Y, Marmorstein R, Wang Z. Chembiochem. 2018 Sep 17;19(18):1988-1997. doi: 10.1002/cbic.201800359. Epub 2018 Aug 17. PubMed
Integrative omics analyses broaden treatment targets in human cancer. Sengupta S, Sun SQ, Huang KL, Oh C, Bailey MH, Varghese R, Wyczalkowski MA, Ning J, Tripathi P, McMichael JF, Johnson KJ, Kandoth C, Welch J, Ma C, Wendl MC, Payne SH, Fenyo D, Townsend RR, Dipersio JF, Chen F, Ding L. Genome Med. 2018 Jul 27;10(1):60. doi: 10.1186/s13073-018-0564-z. PubMed
The atypical MAPK ERK3 potently suppresses melanoma cell growth and invasiveness. Chen M, Myers AK, Markey MP, Long W. J Cell Physiol. 2018 Dec 19. doi: 10.1002/jcp.27994. PubMed
Localization dynamics of endogenous fluorescently labeled RAF1 in EGF-stimulated cells. Surve SV, Myers PJ, Clayton SA, Watkins SC, Lazzara MJ, Sorkin A. Mol Biol Cell. 2019 Feb 15;30(4):506-523. doi: 10.1091/mbc.E18-08-0512. Epub 2018 Dec 26. PubMed
Assembly of Proteins by Free RNA during the Early Phase of Proteostasis Stress. Alriquet M, Martinez-Limon A, Hanspach G, Hengesbach M, Tartaglia GG, Calloni G, Vabulas RM. J Proteome Res. 2019 Jul 5;18(7):2835-2847. doi: 10.1021/acs.jproteome.9b00143. Epub 2019 Jun 18. PubMed
BRAF(V600E)-induced KRT19 expression in thyroid cancer promotes lymph node metastasis via EMT. Wang X, Xu X, Peng C, Qin Y, Gao T, Jing J, Zhao H. Oncol Lett. 2019 Jul;18(1):927-935. doi: 10.3892/ol.2019.10360. Epub 2019 May 14. PubMed
Exhaustion of CD4+ T-cells mediated by the Kynurenine Pathway in Melanoma. Rad Pour S, Morikawa H, Kiani NA, Yang M, Azimi A, Shafi G, Shang M, Baumgartner R, Ketelhuth DFJ, Kamleh MA, Wheelock CE, Lundqvist A, Hansson J, Tegner J. Sci Rep. 2019 Aug 21;9(1):12150. doi: 10.1038/s41598-019-48635-x. PubMed
BRAF inhibitors promote intermediate BRAF(V600E) conformations and binary interactions with activated RAS. Rock R, Mayrhofer JE, Torres-Quesada O, Enzler F, Raffeiner A, Raffeiner P, Feichtner A, Huber RG, Koide S, Taylor SS, Troppmair J, Stefan E. Sci Adv. 2019 Aug 14;5(8):eaav8463. doi: 10.1126/sciadv.aav8463. eCollection 2019 Aug. PubMed
Polymerase synthesis of four-base DNA from two stable dimeric nucleotides. Mohsen MG, Ji D, Kool ET. Nucleic Acids Res. 2019 Oct 10;47(18):9495-9501. doi: 10.1093/nar/gkz741. PubMed
Disrupting ATF4 Expression Mechanisms Provides an Effective Strategy for BRAF-Targeted Melanoma Therapy. Nagasawa I, Koido M, Tani Y, Tsukahara S, Kunimasa K, Tomida A. iScience. 2020 Apr 24;23(4):101028. doi: 10.1016/j.isci.2020.101028. Epub 2020 Mar 31. PubMed
Oncogene-induced senescence in hematopoietic progenitors features myeloid restricted hematopoiesis, chronic inflammation and histiocytosis. Biavasco R, Lettera E, Giannetti K, Gilioli D, Beretta S, Conti A, Scala S, Cesana D, Gallina P, Norelli M, Basso-Ricci L, Bondanza A, Cavalli G, Ponzoni M, Dagna L, Doglioni C, Aiuti A, Merelli I, Di Micco R, Montini E. Nat Commun. 2021 Jul 27;12(1):4559. doi: 10.1038/s41467-021-24876-1. PubMed
Novel GLCCI1-BRAF fusion drives kinase signaling in a case of pheochromocytomatosis. Green BL, Grant RRC, Richie CT, Chatterjee B, Sampaio De Melo M, Barr FG, Pacak K, Agarwal SK, Nilubol N. Eur J Endocrinol. 2022 Jul 1;187(1):185-196. doi: 10.1530/EJE-21-0797. PubMed

If you have published an article using this material, please email us at to have your article added to this page.